Why is Senores Pharma. falling/rising?

As of 05-Sep, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 722.15, reflecting a rise of 20.15 or 2.87%. The stock has shown strong performance recently, with a 1-week return of 4.74% and a 1-month return of 6.76%, significantly outperforming the Sensex, which has remained flat over the same period. Today's trading activity indicates that the stock is close to its 52-week high, just 2.03% away from Rs 736.8, and it reached an intraday high of Rs 732, marking a 4.27% increase. However, there is a noted decline in investor participation, with delivery volume falling by 26.97% against the 5-day average. The company benefits from a low debt-to-equity ratio and impressive growth metrics, including a 100.5% increase in net sales for the latest quarter, which has positively influenced its stock price. In the broader market context, Senores Pharmaceuticals has outperformed the Sensex, which has only gained 1.13% over the past week. Despite the positive short-term performance, there are concerns regarding falling participation from institutional investors, who have reduced their stake by 0.65% in the last quarter. This decline in institutional interest could signal caution among more experienced investors, potentially impacting future stock performance. Overall, while the company shows strong growth and positive financial results, the mixed signals from investor participation and valuation concerns may influence the stock's trajectory moving forward.